These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 31372978)
1. Outcome of CARE: a 6-year national registry of acquired haemophilia A in China. Sun B; Xue F; Feng Y; Sun J; Yu Z; Hou M; Zhang J; Zeng X; Zhao Y; Lian S; Huang M; Niu T; Cui Z; Wu J; Yang R Br J Haematol; 2019 Dec; 187(5):653-665. PubMed ID: 31372978 [TBL] [Abstract][Full Text] [Related]
2. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. Tengborn L; Baudo F; Huth-Kühne A; Knoebl P; Lévesque H; Marco P; Pellegrini F; Nemes L; Collins P; BJOG; 2012 Nov; 119(12):1529-37. PubMed ID: 22901076 [TBL] [Abstract][Full Text] [Related]
3. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies. Holme PA; Brosstad F; Tjønnfjord GE Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896 [TBL] [Abstract][Full Text] [Related]
4. Identifying risk factors and optimizing standard of care for patients with acquired haemophilia A: Results from a Czech patient cohort. Salaj P; Geierová V; Ivanová E; Loužil J; Pohlreichová V; Hrachovinová I; Dulíček P Haemophilia; 2020 Jul; 26(4):643-651. PubMed ID: 32590889 [TBL] [Abstract][Full Text] [Related]
5. Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l'Hémophilie Acquise) registry. Borg JY; Guillet B; Le Cam-Duchez V; Goudemand J; Lévesque H; Haemophilia; 2013 Jul; 19(4):564-70. PubMed ID: 23574453 [TBL] [Abstract][Full Text] [Related]
6. Patients with haemophilia A with inhibitors in China: a national real-world analysis and follow-up. Dou X; Liu W; Poon MC; Zhang X; Wu J; Zeng X; Wu R; Hu Q; Li C; Wang X; Song X; Chen L; Zhang L; Xue F; Yang R Br J Haematol; 2021 Mar; 192(5):900-908. PubMed ID: 33534930 [TBL] [Abstract][Full Text] [Related]
7. Combination of FVIII and low-dose rFVIIa improves haemostasis in acquired haemophilia A patients: a collaborative controlled study. Zhang XH; Zhu XL; Niu T; Sun J; Liu H; Feng R; Yang LH; Wei Q; Ma QH; Wang QM; Feng FE; Fu HX; Mo XD; Lv M; Huang XJ Thromb Res; 2015 May; 135(5):835-40. PubMed ID: 25747536 [TBL] [Abstract][Full Text] [Related]
8. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Knoebl P; Marco P; Baudo F; Collins P; Huth-Kühne A; Nemes L; Pellegrini F; Tengborn L; Lévesque H; J Thromb Haemost; 2012 Apr; 10(4):622-31. PubMed ID: 22321904 [TBL] [Abstract][Full Text] [Related]
9. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Collins P; Baudo F; Knoebl P; Lévesque H; Nemes L; Pellegrini F; Marco P; Tengborn L; Huth-Kühne A; Blood; 2012 Jul; 120(1):47-55. PubMed ID: 22517903 [TBL] [Abstract][Full Text] [Related]
10. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Baudo F; Collins P; Huth-Kühne A; Lévesque H; Marco P; Nemes L; Pellegrini F; Tengborn L; Knoebl P; Blood; 2012 Jul; 120(1):39-46. PubMed ID: 22618709 [TBL] [Abstract][Full Text] [Related]
11. A low-dose rituximab regimen for first-line treatment of acquired haemophilia A. Hunt S; Robertson J; Conn J; Casey J; Royle J; Collins J; Hourigan M; Richmond J; Yang Wang T; Mills A; Mason J Eur J Haematol; 2022 Jan; 108(1):28-33. PubMed ID: 34528303 [TBL] [Abstract][Full Text] [Related]
12. Inhibitor eradication and bleeding management of acquired hemophilia A: a single center experience in China. Ye N; Liu Z; Xu G; Wang X; Wu F; Xu X; Wu W Hematology; 2019 Dec; 24(1):631-636. PubMed ID: 31514689 [No Abstract] [Full Text] [Related]
13. Acquired haemophilia syndrome: pathophysiology and therapy. Elezović I Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():64-8. PubMed ID: 20229686 [TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan. Ogawa Y; Yanagisawa K; Uchiumi H; Ishizaki T; Mitsui T; Gouda F; Ieko M; Ichinose A; Nojima Y; Handa H Int J Hematol; 2017 Jul; 106(1):82-89. PubMed ID: 28299631 [TBL] [Abstract][Full Text] [Related]
15. New protocol for immune tolerance induction in acquired hemophilia. Nemes L; Pitlik E Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874 [TBL] [Abstract][Full Text] [Related]
16. Treatment of Severe Acquired Haemophilia A with Immunosuppressive Agent: A Case Report of One Patient. Škunca Ž; Peraica AP Coll Antropol; 2016 Jun; 40(2):139-43. PubMed ID: 29139630 [TBL] [Abstract][Full Text] [Related]
17. Management of acquired haemophilia A in severe Covid-19: Haemostatic bridging with emicizumab to keep the balance between bleeding and thrombosis. Gelbenegger G; Traby L; Rahimi N; Knöbl P Br J Clin Pharmacol; 2023 Feb; 89(2):908-913. PubMed ID: 36369653 [TBL] [Abstract][Full Text] [Related]
18. Relapse pattern and long-term outcomes in subjects with acquired haemophilia A. Mizrahi T; Doyon K; Dubé E; Bonnefoy A; Warner M; Cloutier S; Demers C; Castilloux JF; Rivard GE; St-Louis J Haemophilia; 2019 Mar; 25(2):252-257. PubMed ID: 30694571 [TBL] [Abstract][Full Text] [Related]
19. FEIBA in the treatment of acquired haemophilia A: results from the prospective multicentre French 'FEIBA dans l'hémophilie A acquise' (FEIBHAC) registry. Borg JY; Négrier C; Durieu I; Dolimier E; Masquelier AM; Lévesque H; Haemophilia; 2015 May; 21(3):330-337. PubMed ID: 25359571 [TBL] [Abstract][Full Text] [Related]
20. Acquired haemophilia: an overview for clinical practice. Kessler CM; Knöbl P Eur J Haematol; 2015 Dec; 95 Suppl 81():36-44. PubMed ID: 26679396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]